HSBC Holdings’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-179,377
Closed -$3.29M 3212
2024
Q1
$3.29M Buy
+179,377
New +$2.85M ﹤0.01% 1268
2021
Q4
Sell
-9,433
Closed -$522K 3389
2021
Q3
$522K Buy
9,433
+5,265
+126% +$276K ﹤0.01% 2225
2021
Q2
$201K Buy
4,168
+197
+5% +$10K ﹤0.01% 2758
2021
Q1
$202K Buy
3,971
+670
+20% +$37.2K ﹤0.01% 2545
2020
Q4
$207K Buy
+3,301
New +$205K ﹤0.01% 2800
2020
Q3
Sell
-4,905
Closed -$205K 2898
2020
Q2
$205K Sell
4,905
-2,354
-32% -$90.4K ﹤0.01% 2354
2020
Q1
$224K Sell
7,259
-2,311
-24% -$92.5K ﹤0.01% 2227
2019
Q4
$389K Buy
+9,570
New +$335K ﹤0.01% 2384

Other funds holding SILK

HSBC Holdings's SILK Position: Q2 2024 in Review

HSBC Holdings sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 179,377 shares — an estimated $3.29M sold.

HSBC Holdings first reported a position in SILK in Q4 2019 and held it in 8 quarters. The position peaked at $3.29M in Q1 2024. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

  • HSBC Holdings reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • HSBC Holdings sold 179,377 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $3.29M.
  • HSBC Holdings first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
  • HSBC Holdings's Silk Road Medical, Inc. Common Stock position peaked at $3.29M in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on HSBC Holdings's 13F filing for Q2 2024, filed 12 Aug 2024.